{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:25:14Z","timestamp":1794086714798,"version":"4.8.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals USA Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008980","name":"Medical College of Wisconsin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.antiviral.2026.106554","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:19:13Z","timestamp":1792106353000},"page":"106554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibition of Porcine Cytomegalovirus\/Porcine Roseolovirus (PCMV\/PRV) replication with antiviral compounds"],"prefix":"10.1016","volume":"255","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6408-7611","authenticated-orcid":false,"given":"H.","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5539-4199","authenticated-orcid":false,"given":"A.","family":"Chelladurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.N.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7692-3619","authenticated-orcid":false,"given":"R.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3868-0403","authenticated-orcid":false,"given":"D.","family":"Eisenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5363-167X","authenticated-orcid":false,"given":"R.","family":"Arav-Boger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2026.106554_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2026.106554_bib2","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2026.106554_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000001418","article-title":"Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory cytomegalovirus infection","author":"Avery","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2026.106554_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/421912","article-title":"Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection","volume":"190","author":"Bidanset","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2026.106554_bib5","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1021\/acs.jmedchem.2c00668","article-title":"Discovery, chemistry, and preclinical development of Pritelivir, a novel treatment option for acyclovir-resistant Herpes Simplex virus infections","volume":"65","author":"Birkmann","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106554_bib6","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/AAC.01972-13","article-title":"In vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of action","volume":"58","author":"Cai","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/ml400529q","article-title":"Digitoxin analogues with improved anticytomegalovirus activity","volume":"5","author":"Cai","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2026.106554_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.antiviral.2019.01.008","article-title":"In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: a systematic literature review","volume":"163","author":"Chemaly","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106554_bib9","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1128\/AAC.01623-15","article-title":"Rapid in vitro evolution of human cytomegalovirus UL56 mutations that confer Letermovir resistance","volume":"59","author":"Chou","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.antiviral.2018.07.013","article-title":"Antiviral activity of maribavir in combination with other drugs active against human cytomegalovirus","volume":"157","author":"Chou","year":"2018","journal-title":"Antivir. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2026.106554_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1034\/j.1399-3062.2001.00004.x","article-title":"Cytomegalovirus drug resistance and clinical implications","volume":"3","author":"Chou","year":"2001","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2026.106554_bib12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/mol.62.3.714","article-title":"Role of the human herpesvirus 6 u69-encoded kinase in the phosphorylation of ganciclovir","volume":"62","author":"De Bolle","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2026.106554_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083542","article-title":"How does a porcine herpesvirus, PCMV\/PRV, induce a xenozoonosis","volume":"26","author":"Denner","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.antiviral.2026.106554_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/xen.70075","article-title":"Porcine Cytomegalovirus\/Porcine roseolovirus (PCMV\/PRV) and antiviral drugs","volume":"32","author":"Denner","year":"2025","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.antiviral.2026.106554_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12449","article-title":"Early weaning completely eliminates porcine cytomegalovirus from a newly established pig donor facility for xenotransplantation","volume":"25","author":"Egerer","year":"2018","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.antiviral.2026.106554_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.899657","article-title":"Progress in xenotransplantation: Immunologic barriers, advances in gene editing, and successful tolerance induction strategies in pig-to-primate transplantation","volume":"13","author":"Eisenson","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2026.106554_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/v9110317","article-title":"Antibody cross-reactivity between porcine Cytomegalovirus (PCMV) and human Herpesvirus-6 (HHV-6)","volume":"9","author":"Fiebig","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2026.106554_bib18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jac\/dkh231","article-title":"Susceptibility of porcine cytomegalovirus to antiviral drugs","volume":"53","author":"Fryer","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib19","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1128\/AAC.00468-10","article-title":"Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir","volume":"54","author":"Gentry","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib20","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1111\/j.1600-6143.2009.02849.x","article-title":"Results of gal-knockout porcine thymokidney xenografts","volume":"9","author":"Griesemer","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2026.106554_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2201422","article-title":"Genetically modified porcine-to-human cardiac xenotransplantation","volume":"387","author":"Griffith","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2026.106554_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41591-024-03429-1","article-title":"Transplantation of a genetically modified porcine heart into a live human","volume":"31","author":"Griffith","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2026.106554_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virol.2014.05.014","article-title":"Genomic organization and molecular characterization of porcine cytomegalovirus","volume":"460\u2013461","author":"Gu","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2026.106554_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25624-1","article-title":"How, where and when to screen for porcine cytomegalovirus (PCMV) in donor pigs for xenotransplantation","volume":"12","author":"Halecker","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2026.106554_bib25","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1038\/s41591-025-03861-x","article-title":"Pig-to-human lung xenotransplantation into a brain-dead recipient","volume":"31","author":"He","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2026.106554_bib26","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1128\/AAC.00893-13","article-title":"Unique and highly selective anticytomegalovirus activities of artemisinin-derived dimer diphenyl phosphate stem from combination of dimer unit and a diphenyl phosphate moiety","volume":"57","author":"He","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib27","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1128\/AAC.00519-12","article-title":"Artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication","volume":"56","author":"He","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1743-422X-8-40","article-title":"Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors","volume":"8","author":"He","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2026.106554_bib29","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1128\/AAC.00571-11","article-title":"Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase","volume":"55","author":"James","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/v18010021","article-title":"Porcine Cytomegalovirus\/Porcine roseolovirus, previously transmitted during xenotransplantation, does not infect human 293T and mouse cells with impaired antiviral defense","volume":"18","author":"Jhelum","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2026.106554_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005967.pub2","article-title":"Artesunate versus quinine for treating severe malaria","volume":"CD005967","author":"Jones","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.antiviral.2026.106554_bib32","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1128\/AAC.00898-12","article-title":"Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene","volume":"56","author":"Kapoor","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib33","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1021\/acs.jmedchem.9b01501","article-title":"Validation and characterization of five distinct novel inhibitors of Human cytomegalovirus","volume":"63","author":"Kapoor","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106554_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01977-25","article-title":"A novel inhibitor of human cytomegalovirus acts through a specific antiviral mechanism that involves the helicase-primase complex","volume":"70","author":"Kapoor","year":"2026","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2005.10.003","article-title":"The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo","volume":"69","author":"Kaptein","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106554_bib36","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1128\/AAC.48.12.4745-4753.2004","article-title":"Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections","volume":"48","author":"Kern","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib37","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1128\/AAC.49.3.1039-1045.2005","article-title":"In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication","volume":"49","author":"Kern","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib38","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1128\/AAC.00978-13","article-title":"Human herpesvirus 6 U69 kinase phosphorylates the methylenecyclopropane nucleosides cyclopropavir, MBX 2168, and MBX 1616 to their monophosphates","volume":"57","author":"Komazin-Meredith","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib39","doi-asserted-by":"crossref","first-page":"8453","DOI":"10.1038\/s41467-025-63153-3","article-title":"Physiologic homeostasis in a living human after Pig kidney Xenotransplantation","volume":"16","author":"Lee","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2026.106554_bib40","doi-asserted-by":"crossref","first-page":"W521","DOI":"10.1093\/nar\/gkae241","article-title":"The EMBL-EBI Job Dispatcher sequence analysis tools framework in 2024","volume":"52","author":"Madeira","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2026.106554_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13521","article-title":"Outcomes of transplant recipients treated with cidofovir for resistant or refractory cytomegalovirus infection","volume":"23","author":"Mehta Steinke","year":"2021","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2026.106554_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcv.2009.05.017","article-title":"Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate","volume":"46","author":"Milbradt","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2026.106554_bib43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(23)00775-4","article-title":"Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report","volume":"402","author":"Mohiuddin","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2026.106554_bib44","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1128\/JVI.76.10.4734-4740.2002","article-title":"Activation of cytomegalovirus in pig-to-primate organ xenotransplantation","volume":"76","author":"Mueller","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106554_bib45","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1034\/j.1600-6143.2003.00192.x","article-title":"Reduced efficacy of ganciclovir against porcine and baboon cytomegalovirus in pig-to-baboon xenotransplantation","volume":"3","author":"Mueller","year":"2003","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2026.106554_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005717","article-title":"Efficacy and mechanism of action of low dose emetine against Human cytomegalovirus","volume":"12","author":"Mukhopadhyay","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106554_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01861-17","article-title":"Digitoxin suppresses Human cytomegalovirus replication via Na(+), K(+)\/ATPase alpha1 subunit-dependent AMP-activated protein kinase and autophagy activation","volume":"92","author":"Mukhopadhyay","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106554_bib48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2006.03.013","article-title":"Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses","volume":"72","author":"Naesens","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106554_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104639","article-title":"Artemisone demonstrates synergistic antiviral activity in combination with approved and experimental drugs active against human cytomegalovirus","volume":"172","author":"Oiknine-Djian","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106554_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00288-18","article-title":"The artemisinin derivative artemisone is a potent inhibitor of Human Cytomegalovirus replication","volume":"62","author":"Oiknine-Djian","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib51","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1021\/acsmedchemlett.4c00117","article-title":"Discovery of broad-spectrum herpes antiviral oxazolidinone amide derivatives and their structure-activity relationships","volume":"15","author":"Plotkin","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2026.106554_bib52","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/AAC.01523-10","article-title":"Benzimidazole analogs inhibit human herpesvirus 6","volume":"55","author":"Prichard","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib53","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0166-3542(95)00058-5","article-title":"Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6","volume":"28","author":"Reymen","year":"1995","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106554_bib54","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014116","article-title":"Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition","author":"Roy","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2026.106554_bib55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1517\/14656560802678138","article-title":"Antiviral treatment of cytomegalovirus infection and resistant strains","volume":"10","author":"Schreiber","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.antiviral.2026.106554_bib56","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/587106","article-title":"Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation","volume":"46","author":"Shapira","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2026.106554_bib57","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1093\/jac\/dkab259","article-title":"Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study","volume":"76","author":"Stern","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00150-23","article-title":"Surveillance and prevention of infection in clinical xenotransplantation","volume":"38","author":"Stewart","year":"2025","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2026.106554_bib59","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2008.01.156","article-title":"Anti-HSV activity of digitoxin and its possible mechanisms","volume":"79","author":"Su","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106554_bib60","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s41586-025-08799-1","article-title":"Gene-modified pig-to-human liver xenotransplantation","volume":"641","author":"Tao","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106554_bib61","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/FTD.0000000000000353","article-title":"Brincidofovir is not a substrate for the human organic anion transporter 1: a mechanistic explanation for the lack of nephrotoxicity observed in clinical studies","volume":"38","author":"Tippin","year":"2016","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.antiviral.2026.106554_bib62","article-title":"Pig-to-human kidney xenotransplants using genetically modified minipigs","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.antiviral.2026.106554_bib63","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2--a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.antiviral.2026.106554_bib64","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1128\/AAC.49.9.3724-3733.2005","article-title":"Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro","volume":"49","author":"Williams-Aziz","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106554_bib65","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.antiviral.2011.03.184","article-title":"Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation","volume":"90","author":"Wolf","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106554_bib66","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/TP.0000000000000232","article-title":"Porcine cytomegalovirus infection is associated with early rejection of kidney grafts in a pig to baboon xenotransplantation model","volume":"98","author":"Yamada","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2026.106554_bib67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nm1172","article-title":"Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue","volume":"11","author":"Yamada","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2026.106554_bib68","article-title":"Genetically engineered pig-to-human liver xenotransplantation","author":"Zhang","year":"2025","journal-title":"J. Hepatol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226002135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226002135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:23:07Z","timestamp":1794086587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354226002135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":68,"alternative-id":["S0166354226002135"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106554","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Porcine Cytomegalovirus\/Porcine Roseolovirus (PCMV\/PRV) replication with antiviral compounds","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106554"}}